FDA Panel Endorses Pfizer Vaccines for 5-to-11-Year-Olds
October 27, 2021
(Axios) – Members of the Food and Drug Administration’s vaccine expert panel Tuesday endorsed a two-dose series of Pfizer-BioNTech’s COVID-19 vaccine for children ages 5–11. The final vote was 17 members in favor, with one member abstaining. Why it matters: While not binding, the decision is a long-awaited step toward getting COVID vaccines in the arms of some of the youngest Americans potentially in time to get many fully vaccinated in advance of the holiday season. (Read Full Article)